A phase II study of ADI-PEG 20 and FOLFOX6 in patients (pts) with advanced hepatocellular carcinoma (HCC) Meeting Abstract
| Authors: | Harding, J. J.; Qin, S.; Yang, T. S.; Yen, C. J.; Chao, Y.; Wang, T. E.; Do, R. K. G.; El Dika, I. H.; Uhlitskykh, K.; Millang, B. M.; Feng, X.; Swe, W.; Johnston, A.; Bomalaski, J. S.; Li, C. F.; O'Reilly, E. M.; Ho, C. L.; Chen, Y. Y.; Abou-Alfa, G. K. |
| Abstract Title: | A phase II study of ADI-PEG 20 and FOLFOX6 in patients (pts) with advanced hepatocellular carcinoma (HCC) |
| Meeting Title: | 2019 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2019 Jan 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-02-01 |
| Language: | English |
| ACCESSION: | WOS:000489107600031 |
| DOI: | 10.1200/JCO.2019.37.4_suppl.TPS477 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS477 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
